Literature DB >> 31639799

A Novel Polymorphism (rs35612982) in CDKAL1 Is a Risk Factor of Type 2 Diabetes: A Case-Control Study.

Yanni Tian1, Jing Xu1, Ting Huang2, Jiaqi Cui1, Wei Zhang3, Wei Song1, Huan Chen1, Pan Huang1, Shujun Yang1, Lu Wang1, Xin He4, Lin Wang5, Wei Cui6.   

Abstract

BACKGROUND: The interaction of environmental factors and genetic factors may contribute to the risk of type 2 diabetes (T2D). We aimed to investigate whether age, gender, body mass index (BMI) and lifestyle factors have an effect on the association between the CDKAL1 polymorphisms and T2D.
METHODS: Eight single nucleotide polymorphisms in CDKAL1 were genotyped by Agena MassARRAY in 508 T2D patients and 503 controls. The association between the CDKAL1 polymorphisms and T2D was evaluated using logistic regression model by calculating OR and 95% CIs.
RESULTS: We found a significant association between CDKAL1 polymorphisms (rs4712523, OR 1.42, p = 9.44 × 10-5; rs4712524, OR 1.38, p = 3.28 × 10-4; rs10946398, OR 1.43, p = 6.21 × 10-5; rs7754840, OR 1.43, p = 6.33 × 10-5; rs35612982, OR 1.34, p = 0.0010; and rs10440833, OR 1.32, p = 0.0018) and T2D risk among the Han population from Northwest China. We also found that genetic variants of CDKAL1 could modify the risk of T2D that might be influenced by age, BMI and the status of smoking and drinking. Besides, rs35612982-CT (p = 0.038) and rs10440833-AT (p = 0.044) genotypes were higher insulin level.
CONCLUSION: CDKAL1 rs35612982 (C/T) polymorphism, as a new polymorphism, was associated with the increased risk of T2D in the Han Chinese population. Moreover, the contribution of CDKAL1 polymorphisms to T2D risk seems to be associated with age, gender, BMI, smoking and drinking.
© 2019 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  CDKAL1 gene; Case-control; Polymorphisms; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31639799     DOI: 10.1159/000503175

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  6 in total

1.  An integrative approach for identification of smoking-related genes involving bladder cancer.

Authors:  Fang Gao; Huiqin Li; Zhenguang Mao; Yanping Xiao; Mulong Du; Shizhi Wang; Rui Zheng; Zhengdong Zhang; Meilin Wang
Journal:  Arch Toxicol       Date:  2022-10-12       Impact factor: 6.168

Review 2.  Involvement of Cdkal1 in the etiology of type 2 diabetes mellitus and microvascular diabetic complications: a review.

Authors:  Chandrachur Ghosh; Neeladrisingha Das; Sarama Saha; Tathagata Kundu; Debabrata Sircar; Partha Roy
Journal:  J Diabetes Metab Disord       Date:  2022-01-13

3.  Association Between CDKAL1, HHEX, CDKN2A/2B and IGF2BP2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes in Uttarakhand, India.

Authors:  Amit K Verma; Yamini Goyal; Deepti Bhatt; Mirza Masroor Ali Beg; Kapil Dev; Mohammed A Alsahli; Arshad Husain Rahmani
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-06       Impact factor: 3.168

Review 4.  Association of vitamin D receptor gene rs739837 polymorphism with type 2 diabetes and gestational diabetes mellitus susceptibility: a systematic review and meta-analysis.

Authors:  Qiaoli Zeng; Dehua Zou; Yue Wei; Yingguang Ouyang; Zhaohang Lao; Runmin Guo
Journal:  Eur J Med Res       Date:  2022-05-07       Impact factor: 4.981

Review 5.  Different Associations Between CDKAL1 Variants and Type 2 Diabetes Mellitus Susceptibility: A Meta-analysis.

Authors:  Qiaoli Zeng; Dehua Zou; Shanshan Gu; Fengqiong Han; Shilin Cao; Yue Wei; Runmin Guo
Journal:  Front Genet       Date:  2022-01-05       Impact factor: 4.599

6.  Association Analysis of LEP Signaling Pathway with Type 2 Diabetes Mellitus in Chinese Han Population from South China.

Authors:  Haibing Yu; Lin Xu; Hao Liu; Jialu Huang; Ling Luo; Rong Chen; Jian Xu; Chunwen Lin; Weiying Chen; Yuxun Xie; Huihuang Yang; Danli Kong; Yuanlin Ding
Journal:  Biomed Res Int       Date:  2021-09-20       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.